Propel Bio Management, LLC 13F Holdings

CIK 0001969764 · LOS ANGELES, CA

As of Sep 30, 2025, Propel Bio Management, LLC reported 16 positions worth $99.9M in its SEC Form 13F filing.

Top 16 holdings

SecurityTickerSectorSharesValue% of portfolio
PLAINS GP HOLDINGS LPPAGPEnergy1,272,360$23.2M23.23%
ACHIEVE LIFE SCIENCES INCACHVHealthcare3,786,425 1.9M11.94%
AKERO THERAPEUTICS INCAKROHealthcare228,884 0.9M10.88%
MILESTONE PHARMACEUTICALS INMIST—5,124,890 0.2M10.26%
APPLIED THERAPEUTICS INCAPLTHealthcare11,285,420$6.8M6.83%
PHATHOM PHARMACEUTICALS INCPHATHealthcare552,927$6.5M6.51%
ABEONA THERAPEUTICS INCABEOHealthcare974,022$5.1M5.15%
DELCATH SYSTEMS INCDCTHHealthcare438,509$4.7M4.72%
CELLDEX THERAPEUTICS INC NEWCLDXHealthcare155,000$4.0M4.01%
TSCAN THERAPEUTICS INCTCRXHealthcare1,932,304$3.5M3.52%
COMPASS PATHWAYS PLCCMPSHealthcare510,000$2.9M2.93%
NEKTAR THERAPEUTICSNKTRHealthcare49,000$2.8M2.79%
JASPER THERAPEUTICS INCJSPRHealthcare1,028,806$2.4M2.45%
ZEVRA THERAPEUTICS INCZVRAHealthcare231,874$2.2M2.21%
VIRIDIAN THERAPEUTICS INCVRDNHealthcare90,000 .9M1.94%
ATHIRA PHARMA INCATHAHealthcare149,279$618.0K0.62%